Theos Remedium Biogenics Private Limited
Founded in 2023 and headquartered in West Bengal, India.
2023 | 24 Parganas, West Bengal (India) | Active
Theos Remedium Biogenics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.60 M
- Company Age 1 Year 8 Months
About Theos Remedium Biogenics
Theos Remedium Biogenics Private Limited (TRBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 June 2023 (One year and eight months 8 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Jagonnath Sinha, Pintu Laha, and Arindom Sen serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497WB2023PTC262952
- Company No.
262952
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Who are the key members and board of directors at Theos Remedium Biogenics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arindom Sen  | Director | 20-Jun-2023 | Current |
| Jagonnath Sinha | Director | 20-Jun-2023 | Current |
| Pintu Laha | Director | 20-Jun-2023 | Current |
Financial Performance of Theos Remedium Biogenics.
Enhance accessibility to Theos Remedium Biogenics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Theos Remedium Biogenics?
Unlock access to Theos Remedium Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Om-Shibom Construction Private Limited
Arindom Sen is a mutual person
- S-S Birbhumi Transport Private Limited
Arindom Sen is a mutual person
- Aerial View-6 Infotech Private Limited
Arindom Sen is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theos Remedium Biogenics?
Unlock and access historical data on people associated with Theos Remedium Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theos Remedium Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theos Remedium Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.